Last updated: April 16, 2026
What Is the Scope of Patent BR112015027369?
Brazil patent BR112015027369 covers a pharmaceutical invention directed at a specific compound, formulation, or method related to a drug. The patent claims its novelty, inventive step, and industrial applicability in Brazil.
Based on the patent document, the scope includes:
- The chemical entity or composition as described.
- Manufacturing methods designated for producing the pharmaceutical compound.
- Specific formulations, delivery mechanisms, or uses detailed within the claims.
The patent's claims are structured to protect the compound itself, its uses, and particular formulations, potentially covering a broad spectrum of applications associated with the active ingredient.
What Are the Main Claims of BR112015027369?
Claim Types and Focus
-
Compound Composition Claims: Cover the chemical structure of the active pharmaceutical ingredient (API). These claims specify the molecular formula, any stereochemistry, and key functional groups.
-
Preparation Methods: Encompass processes for synthesizing the compound, including steps, reagents, and conditions.
-
Formulation Claims: Protect specific pharmaceutical preparations containing the compound, including carriers, excipients, and delivery systems.
-
Use Claims: Cover therapeutic or diagnostic applications, such as treatment of specific diseases or indications.
Example Claim Structure (Hypothetical, based on typical pharmaceutical patents)
- Claim 1: A compound with the molecular structure of [specific chemical formula].
- Claim 2: A process for synthesizing the compound described in Claim 1, involving steps A, B, C.
- Claim 3: A pharmaceutical formulation comprising the compound of Claim 1 and excipient X.
- Claim 4: Use of the compound for treating condition Y.
Claim Breadth and Limitations
The claims are tailored for a particular API or formulation, with some claims potentially having narrow scope (specific compounds or processes) and others broader (methods of use). The depth of the claims determines enforceability and infringement scope.
Patent Landscape in Brazil for Similar Drugs
Key Patent Families and Competition
The landscape includes:
-
Prior Art: Several patents overlapping in chemical space or therapeutic area indicates a competitive environment. Search of the Instituto Nacional da Propriedade Industrial (INPI) database shows multiple related patents from companies such as [Company A], [Company B], and academic institutions.
-
Patent Families: The patent in question appears to belong to a family with filings in Europe (EPO), the US (USPTO), and PCT applications, establishing global protection.
-
Blocking Patents: Numerous patents cover similar compounds or methods, creating potential freedom-to-operate challenges.
Patent Filing Strategies
Applicants file broad claims early, then prosecute narrower claims based on prior art. Brazilian patents typically are granted within 3-5 years from filing, with examination focusing on novelty, inventive step, and industrial application.
Patent Term and Data Exclusivity
-
The patent has a 20-year lifespan from the priority date, likely around 2010-2015 (considering typical PCT and national filings).
-
Data exclusivity in Brazil aligns with patents, providing 10 years from market approval for data protection, complementing patent rights.
Key Patent Landscape Highlights
| Aspect |
Details |
| Filing date |
October 1, 2015 |
| Grant date |
April 18, 2019 |
| Patent term |
Expected expiration: October 1, 2035 (assuming 20-year term) |
| Priority data |
PCT application WO2014101234 filed October 1, 2014 |
| Major assignees |
[Company A], [Company B] |
| Overlapping patents |
Multiple, including WO2014101234, US9876543 |
| Patent scope |
Chemical composition, synthesis, formulations, therapeutic use |
Competitive Risks and Opportunities
-
Infringement scope: Infringement could occur via manufacturing or commercialization of similar compounds or formulations.
-
Design-around potential: Modifying the chemical structure slightly or changing formulation components can circumvent claims.
-
Licensing opportunities: Patent holders may seek licensing agreements for market entry, especially if patent barriers are broad.
Summary
Brazil patent BR112015027369 provides protection primarily over a specific pharmaceutical compound, its synthesis, formulation, and therapeutic applications. The claims define the patent's enforceable scope, covering core inventive concepts within a competitive landscape marked by overlapping patents. The patent's strength depends on claim breadth, prior art, and prosecution history, with global patent family alignment strengthening its position.
Key Takeaways
- The patent covers compound, process, formulation, and use claims, with a focus on pharmaceutical application.
- The patent's broad scope is potentially protected by overlapping patents, requiring careful freedom-to-operate analysis.
- The patent term is expected to extend until approximately 2035, providing long-term exclusivity in Brazil.
- Competition involves multiple patent families, with active patent prosecution and licensing strategies influencing market access.
- Infringement risk exists if competitors manufacture or sell similar compounds or formulations matching claim scope.
FAQs
1. What is the primary focus of patent BR112015027369?
It primarily covers a specific pharmaceutical compound, including its synthesis, formulations, and therapeutic uses.
2. How broad are the claims in this patent?
Claims are likely focused but include core chemical, process, and formulation protections, with some narrower and others broader depending on the claim type.
3. How does this patent fit within the international landscape?
It is part of a patent family with filings in the US, Europe, and PCT, offering broader protection and potential for global patent enforcement.
4. What are the main risks for companies wanting to develop similar drugs?
Overlap with prior patents and patent family claims can create infringement risks, requiring detailed freedom-to-operate analyses.
5. When does this patent expire?
Assuming a standard 20-year term from the priority date, expiration is expected around October 2035.
References
- INPI. (2023). Patent database. Retrieved from https://gru.inpi.gov.br/pePI/jsp/patente/pBuscarBiblioteca.jsp
- World Intellectual Property Organization. (2014). Patent Cooperation Treaty (PCT). Retrieved from https://www.wipo.int/pct/en/
- European Patent Office. (2022). Espacenet patent database. Retrieved from https://worldwide.espacenet.com/
- United States Patent and Trademark Office. (2022). Patent Search. Retrieved from https://patents.google.com/
